APYX MEDICAL CORPORATION's ticker is APYX and the CUSIP is 03837C106. A total of 75 filers reported holding APYX MEDICAL CORPORATION in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $5,030 | +74.7% | 1,000 | 0.0% | 0.00% | – |
Q1 2023 | $2,880 | +23.1% | 1,000 | 0.0% | 0.00% | – |
Q4 2022 | $2,340 | -96.2% | 1,000 | -89.4% | 0.00% | -100.0% |
Q1 2022 | $62,000 | -50.4% | 9,424 | -3.1% | 0.01% | -52.6% |
Q4 2021 | $125,000 | -22.4% | 9,724 | -16.2% | 0.02% | -29.6% |
Q3 2021 | $161,000 | -10.6% | 11,599 | -33.5% | 0.03% | -12.9% |
Q2 2021 | $180,000 | -1.1% | 17,439 | -7.4% | 0.03% | -13.9% |
Q1 2021 | $182,000 | -3.7% | 18,839 | -28.2% | 0.04% | -10.0% |
Q4 2020 | $189,000 | +52.4% | 26,230 | -0.1% | 0.04% | +29.0% |
Q3 2020 | $124,000 | -22.5% | 26,266 | -8.7% | 0.03% | -35.4% |
Q2 2020 | $160,000 | -3.0% | 28,776 | -37.4% | 0.05% | -43.5% |
Q1 2020 | $165,000 | -57.5% | 45,950 | +0.9% | 0.08% | -50.9% |
Q4 2019 | $388,000 | +26.4% | 45,550 | -6.6% | 0.17% | +4.8% |
Q3 2019 | $307,000 | -21.5% | 48,750 | -11.0% | 0.16% | -22.2% |
Q2 2019 | $391,000 | +2.9% | 54,800 | -8.9% | 0.21% | -7.0% |
Q1 2019 | $380,000 | – | 60,150 | – | 0.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Archon Capital Management LLC | 3,452,030 | $11,046,496 | 2.90% |
AIGH Capital Management LLC | 1,895,231 | $6,064,739 | 2.87% |
Taylor Frigon Capital Management LLC | 621,147 | $1,987,670 | 1.10% |
Worth Venture Partners, LLC | 462,606 | $1,480,339 | 0.88% |
PERKINS CAPITAL MANAGEMENT INC | 211,800 | $678 | 0.67% |
PURA VIDA INVESTMENTS, LLC | 836,990 | $2,678,368 | 0.51% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 372,106 | $1,190,739 | 0.19% |
GREENWOOD CAPITAL ASSOCIATES LLC | 301,809 | $965,789 | 0.14% |
RTW INVESTMENTS, LP | 1,777,194 | $5,687,021 | 0.12% |
Legato Capital Management LLC | 140,062 | $448,198 | 0.06% |